Literature DB >> 12089345

Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.

Shinta Cheng1, Sabrina Brzostek, Suzanne R Lee, Anthony N Hollenberg, Steven P Balk.   

Abstract

Nuclear receptor corepressor (NCoR) mediates transcriptional repression by unliganded nuclear receptors and certain steroid hormone receptors (SHRs) bound to nonphysiological antagonists, but has not been found to regulate SHRs bound to their natural ligands. This report demonstrates that NCoR interacts directly with the androgen receptor (AR) and represses dihydrotestosterone-stimulated AR transcriptional activity. The NCoR C terminus, containing the receptor interacting domains, was necessary for repression, which was ablated by mutations in the corepressor nuclear receptor (CoRNR) boxes. In contrast, the NCoR N terminus, containing domains that can recruit histone deacetylases, was not necessary for repression. Binding studies in vitro with a series of glutathione-S-transferase-NCoR and -AR fusion proteins demonstrated a direct interaction that was similarly dependent upon the NCoR corepressor nuclear receptor boxes and AR ligand binding domain and was independent of ligand and helix 12 in the AR ligand binding domain. This NCoR-AR interaction was further demonstrated in mammalian two-hybrid assays and by coimmunoprecipitation of the endogenous proteins from a prostate cancer cell line. Finally, AR transcriptional activity could be enhanced in vivo by sequestration of endogenous NCoR with unliganded thyroid hormone receptor. These results demonstrate that AR, in contrast to other SHRs, is regulated by NCoR and suggest the possibility of developing selective AR modulators that enhance this interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089345     DOI: 10.1210/mend.16.7.0870

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  38 in total

Review 1.  Circadian rhythms and cancer.

Authors:  Sigal Gery; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

2.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

3.  Differential modulation of glucocorticoid and progesterone receptor transactivation.

Authors:  Daniele Szapary; Liang-Nian Song; Yuangzheng He; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2007-12-08       Impact factor: 4.102

4.  Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

Authors:  Joanna K Lempiäinen; Einari A Niskanen; Kaisa-Mari Vuoti; Riikka E Lampinen; Helka Göös; Markku Varjosalo; Jorma J Palvimo
Journal:  Mol Cell Proteomics       Date:  2017-06-13       Impact factor: 5.911

5.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

Authors:  Changmeng Cai; Housheng Hansen He; Sen Chen; Ilsa Coleman; Hongyun Wang; Zi Fang; Shaoyong Chen; Peter S Nelson; X Shirley Liu; Myles Brown; Steven P Balk
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

6.  A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels.

Authors:  Tamzin M Tanner; Sarah Denayer; Bart Geverts; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Lien Spans; Vanessa Dubois; Adriaan B Houtsmuller; Frank Claessens; Annemie Haelens
Journal:  Cell Mol Life Sci       Date:  2010-02-26       Impact factor: 9.261

7.  Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.

Authors:  Myles C Hodgson; Howard C Shen; Anthony N Hollenberg; Steven P Balk
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

8.  Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.

Authors:  Srinivas R Viswanathan; Gavin Ha; Andreas M Hoff; Jeremiah A Wala; Jian Carrot-Zhang; Christopher W Whelan; Nicholas J Haradhvala; Samuel S Freeman; Sarah C Reed; Justin Rhoades; Paz Polak; Michelle Cipicchio; Stephanie A Wankowicz; Alicia Wong; Tushar Kamath; Zhenwei Zhang; Gregory J Gydush; Denisse Rotem; J Christopher Love; Gad Getz; Stacey Gabriel; Cheng-Zhong Zhang; Scott M Dehm; Peter S Nelson; Eliezer M Van Allen; Atish D Choudhury; Viktor A Adalsteinsson; Rameen Beroukhim; Mary-Ellen Taplin; Matthew Meyerson
Journal:  Cell       Date:  2018-06-18       Impact factor: 41.582

9.  The nuclear receptor corepressor has organizational effects within the developing amygdala on juvenile social play and anxiety-like behavior.

Authors:  Heather M Jessen; Mira H Kolodkin; Meaghan E Bychowski; Catherine J Auger; Anthony P Auger
Journal:  Endocrinology       Date:  2010-01-05       Impact factor: 4.736

10.  The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.

Authors:  Sophie S B Giguère; Amanda J Guise; Pierre M Jean Beltran; Preeti M Joshi; Todd M Greco; Olivia L Quach; Jeffery Kong; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.